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Recommendationsa b s t r a c t
Nerve conduction and electromyography studies are generally well tolerated and pose little risk to
patients of serious adverse events in the hands of a well-trained competent practitioner. However, some
patients and certain examinations do carry a higher risk of potential complications. It is good medical
practice to inform patients of any risks, their potential severity and relative frequency. In order to obtain
informed consent a dialogue should take place about the nature, purpose and effects of the studies, so
patients can decide if they wish to undergo the proposed investigation. In this educational review we
identify those procedures and patients at risk, and provide pragmatic practice recommendations for
managing these material risks.
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A. Gechev et al. / Clinical Neurophysiology Practice 1 (2016) 62–66 63In modern medicine it is best practice to explain the investiga-
tive and therapeutic options available to patients, so that they can
take an active role in decisions about their management along with
health professionals. Ideally a practitioner should explain the
potential benefits and risks associated with these, including the
option of either doing nothing or suggesting any alternatives.
Patients should be informed of all serious risks, however infre-
quent, so that they can weigh up the potential benefits against
the material risks for themselves. The purpose of this review,
which includes our pragmatic practice recommendations, is to out-
line the known risks or complications of nerve conduction studies
(NCS) and needle electromyography (EMG), along with their esti-
mated frequency and severity (see Tables 1 and 2) with reference
to evidence-based information where currently available. Unfortu-
nately there is in fact surprisingly little evidence from prospective
studies, and we have therefore based our observations on the rel-
atively small number of review articles and case reports available,
as well as the collective experience and opinion of the authors. The
guidelines of the local Health Provider’s Policies on hand washing,
health and safety (including electrical safety), infection control and
control of hazardous substances to health, should be observed
where applicable for electrodiagnostic assessment, and our recom-
mendations should not supersede the regulations of an employing
Institution. Furthermore it is essential to have equipment properly
maintained and safety tested, to prevent electric shock hazard.
Equally practitioners should be appropriately trained and proven
competent to undertake electrodiagnostic studies as potential mis-
interpretation can lead to over- or under-diagnosis and mis-
prognosis, which in themselves carry significant risks for patients,
although this subject is outside the remit of our review.1. Basic considerations
It is widely recognized in the literature that electrodiagnostic
studies are generally well tolerated (Dumitru et al., 2002; Preston
and Shapiro, 2013,). On the other hand transient mild proceduralTable 1
Classification of the frequency of adverse events.
Very common P1/10
Common (frequent) <1/10 and P1/100
Uncommon (infrequent) <1/100 and P1/1000
Rare <1/1000 and P10,000
Very rare <1/10,000
CIOMS -Council of International Organizations of Medical
Sciences.
Table 2
Severity of adverse events.
Grade 1
Mild
Asymptomatic or mild symptoms; clinical or
diagnostic observations only; intervention not
indicated
Grade 2
Moderate
Minimal, local or noninvasive intervention indicated;
limiting age-appropriate instrumental ADL (preparing
meals, shopping for groceries or clothes, using the
telephone, managing money, etc.)
Grade 3
Severe
Medically significant but not immediately life-
threatening; hospitalization or prolongation of
hospitalization indicated; disabling; limiting self-care
ADL (bathing, dressing and undressing, feeding self,
using the toilet, taking medications, and not
bedridden)
Grade 4
Life-threatening
Urgent medical intervention indicated
Grade 5
Death
Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0.pain and discomfort are very common, and in fact the most fre-
quent ‘‘undesired effect” that patients will experience. The discom-
fort, or mild pain experienced by some patients, following the
application of electrical stimulation during nerve conduction stud-
ies (NCS) is transient and self-limiting and will not initiate or
aggravate pre-existing symptoms beyond the duration of the
actual investigation. Adverse events such as self-limiting mild ten-
derness and/or bruising commonly follow an ‘uncomplicated’ nee-
dle electromyography (EMG) examination. Some patients might be
unable to cooperate with or even tolerate supramaximal electrical
stimulation or needle examination, especially when patients have
been sensitized previously. In the context of consent patients need
to be advised that this might limit the diagnostic yield and sensi-
tivity of the investigation, but could be informed about potential
alternative diagnostic tests (e.g. Magnetic Resonance Imaging in
the investigation of radiculopathy). We recommend documenting
this in the final report. Presyncope and even syncope are well
known to Electromyographers, albeit relatively uncommon
(<1/100).2. Infections
Historically soft tissue infections secondary to needle EMG have
been reported sporadically but are probably very rare (<1/10,000).
Infectious pathogens that have been identified include Staphylococ-
cus epidermidis (Burris and Fairchild, 1986) and an outbreak of
Mycobacterium fortuitum occurred with re-usable needles (Nolan
et al., 1991), but these were mild and self-limiting. Indeed re-
usable needles are now largely outmoded, since the demonstration
that single-fibre EMG can be effectively performed with disposable
fine concentric needle electrodes using a restricted bandpass for
jitter studies. A single disposable needle electrode is typically used
to make multiple insertions in several muscles in the same patient
during needle EMG testing, but there is no evidence to suggest that
multiple insertions into the same patient with a single needle elec-
trode increases the risk of infection. Whether treatment of the skin
with disinfection agents prior to needle insertion reduces the risk
of infection is not known. Infection risk and the role of prophylactic
antibiotics in immune compromised patients and endocarditis risk
in vulnerable patients are largely unknown, but we are not aware
of any incidences of procedure related infection. Vigorous der-
mabrasion and adhesive electrodes can injure the skin, particularly
in very young, elderly or vulnerable patients, and theoretically lead
to either local skin infection and/or act as a portal of entry in a sus-
ceptible patient. When very sticky self-adhesive surface electrodes
are applied to vulnerable skin (e.g. after corticosteroid treatment)
their subsequent removal can lift off skin. It is advisable that broken
and potentially infected skin (e.g. decubitus ulcer) is avoided.
Urticaria changing into vitiligo has been reported in an early
study (Walpin and Reiss, 1966), but not described since to our
knowledge, and may therefore have been co-incidental.3. Lymphoedema
It has been speculated that performing needle EMG in limbs
with significant lymphoedema might theoretically carry an
increased risk of infection (Dumitru et al., 2002). In patients with
gross oedema anywhere on the body skin puncture by needle elec-
trodes may result in weeping of serous fluid. However, no pub-
lished report of cellulitis, infection, or other complications
related to EMG performed in the setting of lymphoedema or after
regional lymph node resection were found (AANEM, 2014). None
the less it is perhaps advisable to avoid needle insertion in lym-
phoedematous regions to avoid potential complications (Al-
Shekhlee et al., 2003) and any distressing exudate. Indeed patients
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often request that needle examination not be performed in the
affected limb.4. Prosthetic joints and metal osteosynthesises
Based upon current published literature no reports of complica-
tions related to needle EMG in patients with prosthetic joints were
found (AANEM, 2014). It is uncertain whether the electrical NCSs
stimulation near metal osteosynthesis after bone fractures would
present a potential risk of electrical injury. Theoretically the risk
might increase in patients with external fixation apparatus (e.g. Ili-
zarov), but at present this should not be a contraindication to NCS/
EMG.5. Bleeding, haematoma and compartment syndromes
Inserting EMG needles into skeletal muscles is generally well
tolerated with minimal or no discernable bleeding. Amongst the
wide range of coexisting medical conditions thrombocytopenia
(platelets below 50,000/mm3), chronic renal failure and coagu-
lopathies (either acquired or inherited) are more frequently associ-
ated with an increased risk of bleeding during invasive procedures.
Similarly it is possible for individuals on anticoagulation,
anti-platelets agents and some other drugs (e.g. non-steroidal
anti-inflammatory drugs and ‘over the counter’ herbal medica-
tions) to bleed significantly following a needle study (Preston
and Shapiro, 2013).
There are a few very rare case reports in the literature (proba-
bly < 1/10,000) of medically significant haematomas and resultant
potentially severe compartment syndromes, the majority in
patients with known bleeding disorders, either medically induced
or acquired (Al-Shekhlee et al., 2003; Baba et al., 2005; Butler
and Dewan, 1984; Hough et al., 2003; Vaienti et al., 2005). The fre-
quently cited study by Caress et al. (1996) found subclinical hae-
matomas in paraspinal muscles after needle EMG in 5 of 17
patients, on retrospective review of Magnetic Resonance Imaging
(MRI). However, a later retrospective study of 370 patients did
not find evidence of any EMG-related MRI-evident paraspinal hae-
matomas, including 161 patients who were on medications know
to affect coagulation (Gertken et al., 2011). However, in a prospec-
tive study of anticoagulated patients (on warfarin, aspirin or
clopidogrel) subclinical haematomas were visualized by ultra-
sonography in 3 out of 158 patients, compared with none of 51
control patients not on these agents (Lynch et al., 2008). The same
group in a later study prospectively examined over 300 muscles
with ultrasound after EMG and showed no statistical difference
in the incidence of haematoma between anticoagulated patients
and case control patients without blood thinning medication;
although two subclinical haematomas were detected in the antico-
agulated group confirming the higher theoretical risk of possible
progression to significant haematomas (Boon et al., 2012). Taken
together the available evidence indicates that subclinical or
asymptomatic haematomas occur with an incidence of about 1 to
2/100 examined muscles; and given that generally multiple mus-
cles are examined the risk for an individual patient is therefore
in fact common. However, clinically significant haematomas are
likely to be uncommon, although in a survey of 47 electro-
diagnostic laboratories 4 retrospectively reported at least one case
of bleeding in anticoagulated patients, requiring medical or surgi-
cal intervention (Gruis et al., 2006).
Based on the available literature the requirement of patients to
discontinue warfarin or aspirin before undergoing EMG is some-
what controversial, given that the risk of discontinuing antithrom-
botic medications can cause thromboembolic complications. Therecommendation of a subcommittee of the American Academy of
Neurology is that warfarin and aspirin ‘‘might be associated with
no increased clinically important bleeding with EMG” (Armstrong
et al., 2013). Furthermore, there is evidence that ‘bridging’ patients
in atrial fibrillation on Warfarin with heparin for surgical proce-
dures did not reduce embolic complications, but did lead to an
increased risk of major bleeding (Douketis et al., 2015). Moreover,
a study on over 200 patients undergoing implantation of a cardiac
rhythm management device compared patients with uninter-
rupted warfarin therapy, or in whom warfarin was paused for
2 days, and found no increase of peri-procedural bleeding compli-
cations (Airaksinen et al., 2013). However, it is currently unclear
whether these results from surgical procedures with visual inspec-
tion and accurate haemostasis can be extrapolated to blind needle
exploration of a muscle.
We recommend that a recent (within 48 h) International Nor-
malized Ratio (INR) is measured in patients taking a stable dose
of Warfarin and that certain measures, such as examination of
superficial muscles with a fine gauge needle, may reduce the risk
of clinically significant bleeding. It is probably wise to avoid needle
EMG examination in patients’ whose INR lies outside the therapeu-
tic range. If the INR is unknown the urgency of the clinical question
that is being addressed should be determined, along with the
patients’ expectations, to assess whether the examination should
be deferred to a later date.
Further studies are clearly needed to evaluate the relative risk
frequency of clinically relevant haematomas. Little is known
whether the experience of the examiner, anatomical site of the
muscle examined (i.e. limb versus paraspinal) or gauge of needle
used has any influence on the bleeding risk; or whether the knowl-
edge of the examiner of the compromised coagulation status of a
patient has any impact. Most available evidence examined patients
taking Warfarin and less is known about the new oral anticoagu-
lant agents such as Xa inhibitors (e.g. rivaroxaban).6. Electrodiagnostic assessment of pregnant women
No known contraindications exist for performing NCS and nee-
dle EMG in pregnant patients. In addition, no complications from
these procedures have been reported in the recent neurophysiol-
ogy literature. Evoked response testing, likewise, has not been
reported to cause any problems when performed during pregnancy
(AANEM, 2014).7. Pneumothorax, peritonitis and local nerve injury
Several reports document that it is possible to cause pneumoth-
orax, the most potentially serious (i.e. life threatening) iatrogenic
complication of needle EMG, when attempting to examine certain
‘‘high risk” muscles such as the diaphragm, serratus anterior,
supraspinatus, rhomboids, cervical or thoracic paraspinal muscles
(Honet et al., 1986; Honet, 1988; Miller, 1990; Reinstein et al.,
1987). In the most recent paper Kassardjian et al. (2016) retrospec-
tively found over an 18 year period a symptomatic pneumothorax
caused by EMG examination in 7 patients out of 64,490 patients,
who had undergone EMG evaluation of 71,782 high risk muscles.
Pneumothorax became apparent within 1 h in 6/7 patients and in
1 patient after 24 h. Overall the complication frequency is therefore
rare (<1/1000) but dependent up on the target muscle. The highest
risk was for the serratus anterior muscle with about 1/200 exami-
nations and less than 1/500 for the diaphragm (i.e. uncommon).
These figures are in agreement with previous assessments of fewer
patients (Bolton, 1993; Saadeh et al., 1993; Sander et al., 1997).
A potentially hazardous penetration of the peritoneum during
chest wall or abdominal musculature by needle EMG examination
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of any reported cases.
It is feasible that an EMG needle may also injure a nerve by
direct intraneural puncture during near nerve stimulation or if a
nerve travels near or through the muscle of interest. Although
there are no reported cases of routine EMG needle-induced nerve
trauma, there are reports of nerve trauma from other types of nee-
dles (Davison et al., 1996; Horowitz, 1994), including deliberate
insertion of small needles into nerves in microneurography
(Eckberg et al., 1989).8. Electrically sensitive patients
8.1. Studies in the critical care unit
The most common ways a critically ill patient can become elec-
trically sensitive are: (a) when the normal protective function of
the skin is breached by intra-venous and intra-arterial catheters
with leakage and spills around the catheter site, and (b) when
the large volume of ‘protective’ soft tissue which surrounds the
heart (i.e. the trunk) is bypassed by intra-cardiac catheters and
external pacing wires such that small, otherwise harmless cur-
rents, become potentially lethal by direct conduction to the heart
(‘‘microshock”) (Al-Shekhlee et al., 2003). A small study on 20
patients suggested that there was no risk of cardiac conduction
abnormalities or malfunction of implanted cardiac pacemakers or
cardiac defibrillators, if routine NCS were performed when short
saline filled cannulae were placed in the antecubital fossa or at
the wrist (Mellion et al., 2010).8.2. Implanted pacemakers and cardiac defibrillators
Implanted Cardiac Pacemakers (ICPs) and Implanted Cardiac
Defibrillators (ICDs) both have an electronic sensing as well as stim-
ulation function. In theory stimulation during NCSs might be mis-
taken as an abnormal cardiac rhythm (Almeida and Buckingham,
1993; Bardy et al., 1989; Grimm et al., 1993; LaBan et al., 1988;
Preston and Shapiro, 2013; Romano et al., 1993) that may cause
anti-tachycardia pacers to deliver a countershock. It is known that
transcutaneous electrical nerve stimulation (TENS), with stimulus
frequency, pulse duration and current parameters comparable to
those used in neurophysiological investigation, can interfere with
ICD function (Holmgren et al., 2008). The most recent study has
shown that this situation is, however, very unlikely to occur in rou-
tine electrodiagnostic testing, as evidenced by the lack of significant
ECG change during nerve stimulation in a study of 77 patients
(Ohira et al., 2013).When the pacemakerwas deliberately inhibited
in 30 of these patients there were minor symptoms including light-
headedness, heart palpitations and tingling of the fingers accompa-
nied by heart rate changes. This contrasted with the symptom free
‘control group’ of 47 patients whose implanted cardiac devices
were not inhibited by a magnet. Based on this small study the
authors advised not to inactivate the device (Ohira et al., 2013).
Similar observations showed that there is no demonstrable risk of
peripheral NCSs, even at the left supraclavicular fossa, interfering
with an ICP or ICD using a bipolar sensing configuration (Schoeck
et al., 2007). Early devices with unipolar pacing circuitry have an
increased signal pick-up area and make it theoretically possible to
detect volume conducted potentials from NCS. There is a case
report of an 89 year old man with a unipolar ICP whose cardiac out-
put was lost during facial nerve stimulation, but returned after ces-
sation of nerve stimulation (Schoeck et al., 2007).
Incidentally a reported implantable pacemaker failure, thought
to be related to phrenic nerve stimulation (Wicks et al., 1978), rep-
resents a rather different situation than occurs in NCS and is moreakin to the interference that may occur from powerful external
electromagnetic devices, such as magnetic resonance imaging or
a magnet placed over the pulse generator. However, complete inhi-
bition of a unipolar cardiac pacemaker in conjunction with an
interscalene nerve stimulator (utilized for regional anesthesia)
has been reported (Engelhardt et al., 2007).
A study of fourteen patients undergoing insertion of 10 ICDs
and 4 ICPs under general anaesthesia received Repetitive nerve
stimulation of the median, axillary, and spinal accessory nerves
at 2 Hz and 50 Hz. Noise due to electromagnetic interference was
visible in 2 ICDs, but only with stimulation at neck and supraclav-
icular sites and without spurious tachyarrhythmia. With 4 pace-
makers electromagnetic interference led to pacing inhibition
with 3 and a pause in 2, both of which were then programmed
to a unipolar sensing configuration. (Cronin et al., 2013).
In general terms, routine NCS appear to be safe in patients with
modern bipolar implanted cardiac devices. However, we recom-
mend that NCS should not be performed in patients with external
pacing wires or intracardiac catheters. As regards pacemakers with
unipolar sensing and implanted cardiac defibrillators there are lim-
ited data and knowledge gaps, such that we recommend a dialogue
with the patient and their cardiologist about the theoretical risks.
Some device manufacturers and cardiologists advise that the
devices should be deactivated, and in the spirit of engagement
we feel patients should be offered this, as it is quite easy to under-
take whilst monitoring the ECG.
8.3. Implanted deep brain stimulators (DBS) and Vagal nerve
stimulators (VNS)
Implanted DBS and VNS are rarely known to interfere with EMG
recording (Bejanishvili et al., 2005; Nandedkar et al., 2013). These
artifacts could render findings un-interpretable and potential
problems in performing the studies (St John Edward Barker et al.,
2010). Prior arrangement with patients and their specialist nurses
is required to switch the device off during EMG studies.
9. Conclusion
Ultimately a clinical discussion in each individual case with the
patient, and where relevant their primary Physician, should assess
whether the risk of complications is greater than the diagnostic
and prognostic benefit of the information to be obtained from an
electrodiagnostic test. We have provided pragmatic recommenda-
tions based on the information available in the limited literature,
and our clinical experience, about the level and severity of risks.
We have outlined situations where the evidence suggests that
NCS and EMG are safe, but where a patient themselves may have
misgivings. Both NCS and EMG very commonly cause procedural
discomfort, whilst needle EMG commonly causes bruising and
asymptomatic haematoma, but clinically significant haematoma
and their sequelae are uncommon. The most serious complication
of needle EMG is pneumothorax, depending on the muscle exam-
ined, but overall this is rare, and clinically significant infection is
very rare.
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